---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-049103"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2026-07-22T10:58:24+00:00"
generated_at: "2026-07-22T11:00:05.454990+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BD EVP Mike Garrison to retire Oct. 2, 2026; BioPharma Systems to report directly to CEO

## Summary
- Michael D. Garrison, EVP and President of Medical Essentials and BioPharma Systems, will retire effective Oct. 2, 2026.
- Garrison will remain in his role through the end of the fiscal year to support transition.
- A comprehensive search is underway for the next President of Medical Essentials.
- BioPharma Systems segment will report directly to Chairman, CEO and President Tom Polen, streamlining the operating model.
- Garrison spent over 20 years at BD, holding leadership roles including president of Medical segment and Medication Management Solutions.

## SEC filing metadata
- accession: 0001628280-26-049103
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2026-07-22T10:58:24+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000162828026049103/0001628280-26-049103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000162828026049103/bdx-20260719.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-049103
- JSON: https://secwatch.observer/filing/0001628280-26-049103.json
- Plain text: https://secwatch.observer/filing/0001628280-26-049103.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.